• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体亲属肝供体中的大泡性脂肪变性:活检结果与肝脏CT衰减指数及体重指数的相关性

Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index.

作者信息

Jehangir Maham, Nazir Rashed, Jang Aisha, Rana Atif, Rafique Salman, Dar Faisal Saud

机构信息

Department of Radiology, Shifa International Hospital, Islamabad, Pakistan.

Department of Gastroenterology and Liver Transplant, Shifa International Hospital, Islamabad, Pakistan.

出版信息

Clin Transplant. 2016 Sep;30(9):1016-20. doi: 10.1111/ctr.12782. Epub 2016 Jul 2.

DOI:10.1111/ctr.12782
PMID:27291347
Abstract

BACKGROUND

Hepatic steatosis threatens post-transplant graft survival; therefore, pre-operative quantification of steatosis is crucial. Gold standard for evaluation is donor liver biopsy but it is invasive. An alternative non-invasive method is a calculation of CT liver attenuation index. BMI can be an independent factor predicting grade of steatosis but it is necessary to re-define appropriate BMI cut-off points that are specific for Asians.

OBJECTIVE

To retrospectively analyze CT LAI and BMI for quantitative assessment of macrovesicular steatosis in living related liver donors, using histological analysis as gold standard.

MATERIALS AND METHODS

A radiologist blinded to histological grading calculated mean CT hepatic attenuation in 48 potential living related liver donors.

RESULTS

CT-derived LAI correctly predicted steatosis in all except 1 patient. Parametric analysis for CT LAI and BMI showed overall weak positive correlation. No significant association was found between BMI and biopsy findings.

CONCLUSION

Liver biopsy remains a gold standard for evaluation of steatosis. CT LAI of ≤0 correlates well with significant hepatic steatosis and biopsy may be avoided in such cases. Biopsy may be reserved for patients with CT LAI between 1 and 5. BMI alone is not a good predictor of hepatic steatosis in our study population.

摘要

背景

肝脂肪变性会威胁移植后移植物的存活;因此,术前对脂肪变性进行量化至关重要。评估的金标准是供体肝活检,但它具有侵入性。一种替代的非侵入性方法是计算CT肝脏衰减指数。BMI可能是预测脂肪变性分级的独立因素,但有必要重新定义适合亚洲人的合适BMI切点。

目的

以组织学分析作为金标准,回顾性分析CT肝脏衰减指数(CT LAI)和BMI对活体亲属肝供体中重度脂肪变性的定量评估。

材料与方法

一名对组织学分级不知情的放射科医生计算了48名潜在活体亲属肝供体的平均CT肝脏衰减值。

结果

除1例患者外,CT衍生的LAI正确预测了脂肪变性。对CT LAI和BMI的参数分析显示总体呈弱正相关。未发现BMI与活检结果之间存在显著关联。

结论

肝活检仍然是评估脂肪变性的金标准。CT LAI≤0与显著肝脂肪变性相关性良好,在此类情况下可避免活检。活检可保留给CT LAI在1至5之间的患者。在我们的研究人群中,单独BMI并不是肝脂肪变性的良好预测指标。

相似文献

1
Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index.活体亲属肝供体中的大泡性脂肪变性:活检结果与肝脏CT衰减指数及体重指数的相关性
Clin Transplant. 2016 Sep;30(9):1016-20. doi: 10.1111/ctr.12782. Epub 2016 Jul 2.
2
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.活体亲属供肝者的大泡性肝脂肪变性:CT与组织学检查结果的相关性
Radiology. 2004 Jan;230(1):276-80. doi: 10.1148/radiol.2301021176.
3
Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors.体重指数和非增强CT作为潜在肝脏供体肝脂肪变性的预测指标
Transplant Proc. 2019 Sep;51(7):2373-2378. doi: 10.1016/j.transproceed.2019.02.047. Epub 2019 Aug 8.
4
Preoperative Evaluation of Liver Parenchyma of Potential Donors in Living Donor Liver Transplantation.活体肝移植中潜在供体肝脏实质的术前评估
Transplant Proc. 2019 Sep;51(7):2379-2382. doi: 10.1016/j.transproceed.2019.04.070.
5
Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.未增强CT评估活体肝供者的大泡性肝脂肪变性:视觉分级与肝脏衰减指数的比较
Radiology. 2007 Aug;244(2):479-85. doi: 10.1148/radiol.2442061177.
6
Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio.基于计算机断层扫描肝脏与脾脏衰减比的尸体供体大泡性肝脂肪变性的无创评估
Liver Transpl. 2015 May;21(5):690-5. doi: 10.1002/lt.24105.
7
Noninvasive evaluation of graft steatosis in living donor liver transplantation.活体肝移植中移植肝脂肪变性的无创评估
Transplantation. 2004 Nov 27;78(10):1501-5. doi: 10.1097/01.tp.0000140499.23683.0d.
8
Body mass index as a predictor of hepatic steatosis in living liver donors.体重指数作为活体肝供者肝脂肪变性的预测指标。
Liver Transpl. 2001 May;7(5):409-14. doi: 10.1053/jlts.2001.23787.
9
The Assessment of Hepatosteatosis in Living-Donor Liver Transplant: Comparison of Liver Attenuation Index and Histopathologic Results.活体肝移植中肝脂肪变性的评估:肝脏衰减指数与组织病理学结果的比较。
Exp Clin Transplant. 2017 Feb;15(1):69-77. doi: 10.6002/ect.2015.0043. Epub 2015 Jul 29.
10
Body mass index evaluating donor hepatic steatosis in living donor liver transplantation.评估活体肝移植供体肝脂肪变性的体重指数
Transplant Proc. 2009 Nov;41(9):3556-9. doi: 10.1016/j.transproceed.2009.06.235.

引用本文的文献

1
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue.肝移植后代谢功能障碍相关脂肪性肝病(MASLD):一个新出现问题的叙述性综述
J Clin Med. 2024 Jun 30;13(13):3871. doi: 10.3390/jcm13133871.
2
Associations of Fatty Liver Disease With Recovery After Traumatic Injury.非酒精性脂肪性肝病与创伤后恢复的关系。
J Surg Res. 2023 Nov;291:270-281. doi: 10.1016/j.jss.2023.06.014. Epub 2023 Jul 20.
3
Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients.
胰腺脂肪与 2 型糖尿病患者在胰高血糖素刺激试验中 C 肽增量的纵向下降有关。
J Diabetes Investig. 2020 Jan;11(1):80-87. doi: 10.1111/jdi.13108. Epub 2019 Jul 27.
4
Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.MRI-PDFF 无创定量评估肝脂肪作为 NASH 试验的终点。
Hepatology. 2018 Aug;68(2):763-772. doi: 10.1002/hep.29797.